CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock Cash Flow
NASDAQ:CRBP - Nasdaq - US21833P3010 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -57.95M | -40.21M | -44.60M | -42.35M | -45.64M | |||
| Depreciation Amortization | 422.00K | 588.00K | 640.60K | 760.00K | 1.00M | |||
| Change In Working Capital | -6.44M | -6.51M | 3.27M | -4.02M | -15.70M | |||
| Interest Paid | 1.84M | 2.82M | 2.61M | 1.97M | 1.74M | |||
| Other non cash items | 6.08M | 4.33M | 4.59M | 8.06M | 12.15M | |||
| OPERATING CASH FLOW | -57.81M | -41.79M | -36.10M | -37.54M | -48.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -10.00K | -50.00K | |||
| Other Investing Activity | 29.56M | -121.31M | 35.64M | 30.09M | -73.36M | |||
| INVESTING CASH FLOW | 29.56M | -121.31M | 35.64M | 30.07M | -73.42M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -10.90M | -15.48M | -2.87M | -530.00K | 60.00K | |||
| Stock Issued/Repurchased | 36.06M | 182.06M | 244.30K | 0.00 | 62.59M | |||
| Other Financing Activity | N/A | N/A | -190.90K | 0.00 | -1.82M | |||
| FINANCING CASH FLOW | 24.58M | 166.58M | -2.82M | -530.00K | 60.82M | |||
| CHANGE IN CASH | -3.68M | 3.47M | -3.28M | -8.00M | -60.78M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -57.81M | -41.79M | -36.10M | -37.54M | -48.18M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -10.00K | -50.00K | |||
| FREE CASH FLOW | -57.81M | -41.79M | -36.10M | -37.55M | -48.23M | |||
All data in USD